Wu Woffles T L, Liew Steven, Chan Henry H, Ho Wilson W S, Supapannachart Nantapat, Lee Hong-Ki, Prasetyo Adri, Yu Jonathan Nevin, Rogers John D
Camden Medical Centre, Woffles Wu Aesthetic Surgery and Laser Centre, 1 Orchard Boulevard, Suite #09-02, Singapore, 249615, Singapore.
Shape Clinic, Sydney, Australia.
Aesthetic Plast Surg. 2016 Apr;40(2):202-14. doi: 10.1007/s00266-016-0608-y. Epub 2016 Feb 18.
The desire for and use of nonsurgical injectable esthetic facial treatments are increasing in Asia. The structural and anatomical features specific to the Asian face, and differences from Western populations in facial aging, necessitate unique esthetic treatment strategies, but published recommendations and clinical evidence for injectable treatments in Asians are scarce.
The Asian Facial Aesthetics Expert Consensus Group met to discuss current practices and consensus opinions on the cosmetic use of botulinum toxin and hyaluronic acid (HA) fillers, alone and in combination, for facial applications in Southeastern and Eastern Asians. Consensus opinions and statements on treatment aims and current practice were developed following discussions regarding pre-meeting and meeting survey outcomes, peer-reviewed literature, and the experts' clinical experience.
The indications and patterns of use of injectable treatments vary among patients of different ages, and among Asian countries. The combination use of botulinum toxin and fillers increases as patients age. Treatment aims in Asians and current practice regarding the use of botulinum toxin and HA fillers in the upper, middle, and lower face of patients aged 18 to >55 years are presented.
In younger Asian patients, addressing proportion and structural features and deficiencies are important to achieve desired esthetic outcomes. In older patients, maintaining facial structure and volume and addressing lines and folds are essential to reduce the appearance of aging. This paper provides guidance on treatment strategies to address the complex esthetic requirements in Asian patients of all ages.
This journal requires that the authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
在亚洲，对面部非手术注射美容治疗的需求和使用正在增加。亚洲人面部特有的结构和解剖特征，以及与西方人群在面部衰老方面的差异，需要独特的美容治疗策略，但针对亚洲人注射治疗的已发表建议和临床证据却很少。
亚洲面部美学专家共识小组召开会议，讨论肉毒毒素和透明质酸（HA）填充剂单独或联合用于东南亚和东亚人面部美容的当前实践和共识意见。在讨论会前和会中调查结果、同行评审文献以及专家临床经验之后，就治疗目标和当前实践形成了共识意见和声明。
不同年龄患者以及不同亚洲国家之间，注射治疗的适应症和使用模式各不相同。随着患者年龄增长，肉毒毒素和填充剂联合使用的情况增多。文中介绍了亚洲人的治疗目标以及18岁至55岁以上患者在面部上、中、下区域使用肉毒毒素和HA填充剂的当前实践。
对于年轻的亚洲患者，解决比例、结构特征和缺陷对于实现理想的美学效果很重要。对于老年患者，维持面部结构和容积以及解决皱纹和褶皱对于减少衰老外观至关重要。本文为满足各年龄段亚洲患者复杂美学需求的治疗策略提供了指导。
证据水平V：本刊要求作者为每篇文章指定证据水平。有关这些循证医学评级的完整描述，请参阅目录或在线作者指南www.springer.com/00266。
